Research location
Eldoret
Kenya
Advertisement
Research activity in Eldoret
KenyaCureCurrent currently publishes aggregate city-level research activity for this location: 45 trials and 45 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Eldoret
45 linked trials · page 1 of 1The Alama Project: Autism Outcomes and Neurobehavioral Markers in Young Children Born to Mothers With HIV in KenyaNCT06703125 · 2025-02-11 · 1 site observation
RECRUITING
Measuring Adverse Pregnancy and Newborn Congenital OutcomesNCT04405700 · 2020-09-29 · 1 site observation
RECRUITING
The DART DELIVER-02 StudyNCT07217379 · 2025-10-02 · 1 site observation
SUSPENDED
Data Science and Qualitative Research for Decision Support in the HIV Care CascadeNCT06604663 · 2024-05-20 · 1 site observation
ENROLLING_BY_INVITATION
Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and AdultsNCT06062238 · 2024-03-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Long-Acting Treatment in Adolescents (LATA)NCT05154747 · 2023-06-22 · 1 site observation
UNKNOWN
Adapting an Adolescent Friendly PrEP Program for Uasin Gishu County-KenyaNCT05545449 · 2022-09-14 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)NCT05296798 · 2022-07-18 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast CancerNCT05415215 · 2022-07-05 · 1 site observation
COMPLETED
HIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir (DTG) Based RegimenNCT06285110 · 2022-06-13 · 1 site observation
COMPLETED
Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of ConcernNCT05168813 · 2021-12-01 · 1 site observation
COMPLETED
A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer)NCT04961996 · 2021-08-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Pomalidomide in Treating Patients With Kaposi Sarcoma and Human Immunodeficiency Virus InfectionNCT03601806 · 2021-04-26 · 1 site observation
COMPLETED
Harambee: Integrated Community-based HIV/NCD Care & Microfinance Groups in KenyaNCT04417127 · 2020-11-26 · 1 site observation
COMPLETED
Strengthening Referral Networks for Management of Hypertension Across the Health System (STRENGTHS)NCT03543787 · 2020-01-17 · 1 site observation
UNKNOWN
Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLDNCT04050449 · 2019-10-28 · 1 site observation
COMPLETED
HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPVNCT03284866 · 2019-07-31 · 1 site observation
COMPLETED
Project My Heart Your Heart: Pacemaker ReuseNCT04016870 · 2018-10-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Ped HIV - Echo Study: KenyaNCT03228966 · 2017-09-12 · 1 site observation
COMPLETED
Virologic Treatment Failure and Drug Resistance in HIV-infected Kenyan Children (RESPECT)NCT03120065 · 2017-04-24 · 1 site observation
COMPLETED
Bridging Income Generation With Group Integrated CareNCT02501746 · 2017-02-06 · 1 site observation
COMPLETED
Intravenous Chemotherapy or Oral Chemotherapy in Treating Patients With Previously Untreated Stage III-IV HIV-Associated Non-Hodgkin LymphomaNCT01775475 · 2016-09-15 · 1 site observation
COMPLETED
Stratification of Risk of Diabetes in Early PregnancyNCT03005600 · 2016-02-01 · 1 site observation
UNKNOWN
Factors Predicting Persistence of Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan WomenNCT04045652 · 2015-09-21 · 1 site observation
COMPLETED
Prospective Study of Lopinavir Based ART for HIV Infected childreN Globally (LIVING Study)NCT02346487 · 2015-09-01 · 1 site observation
COMPLETED
Optimizing Linkage and Retention to Hypertension Care in Rural KenyaNCT01844596 · 2014-04-01 · 1 site observation
COMPLETED
A Cluster-Randomized Trial of Ultrasound Use to Improve Pregnancy Outcomes in Low Income Country SettingsNCT01990625 · 2014-04-01 · 1 site observation
COMPLETED
Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-InfectedNCT01632891 · 2014-01-10 · 1 site observation
COMPLETED
A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line TreatmentNCT01709084 · 2013-10-02 · 1 site observation
COMPLETED
Clinical Decision-support Reminders to Improve IPT Initiation Among HIV Positive Adults in Western KenyaNCT01934309 · 2013-09-01 · 1 site observation
COMPLETED
Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIVNCT01601626 · 2013-07-13 · 1 site observation
TERMINATED
Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral TherapyNCT01825031 · 2013-06-01 · 1 site observation
COMPLETED
SCOPE: Strategies to Combine PrEP With Prevention EffortsNCT01832571 · 2013-06-01 · 1 site observation
WITHDRAWN
Patient-Centered Disclosure Intervention for HIV-Infected ChildrenNCT01947764 · 2012-08-01 · 1 site observation
COMPLETED
A Stage 2 Cognitive-behavioral Trial: Reduce Alcohol First in Kenya InterventionNCT01503255 · 2012-07-01 · 1 site observation
COMPLETED
Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)NCT01404312 · 2012-05-23 · 1 site observation
COMPLETED
REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) TreatmentNCT01380080 · 2011-10-01 · 1 site observation
COMPLETED
Computerized Counseling to Promote Positive Prevention and HIV Health in KenyaNCT01015989 · 2011-09-01 · 1 site observation
COMPLETED
School Support as Structural HIV Prevention for Adolescent Orphans in KenyaNCT01501864 · 2011-07-01 · 1 site observation
COMPLETED
High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected IndividualsNCT00885703 · 2010-04-16 · 1 site observation
COMPLETED
Europe-Africa Research Network for Evaluation of Second-line TherapyNCT00988039 · 2010-03-01 · 1 site observation
COMPLETED
Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant CouplesNCT00557245 · 2008-05-01 · 1 site observation
COMPLETED
NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV TransmissionNCT00089505 · 2006-11-01 · 1 site observation
COMPLETED
Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for TuberculosisNCT00108862 · 2006-08-01 · 1 site observation
COMPLETED
Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV TransmissionNCT00194519 · 2004-11-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.